MwanzoNL15001WM • ETR
add
Qiagen NV
Bei iliyotangulia
€ 42.59
Bei za mwaka
€ 37.63 - € 47.36
Thamani ya kampuni katika soko
8.40B EUR
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 521.20M | 2.36% |
Matumizi ya uendeshaji wa biashara | 307.82M | 46.13% |
Mapato halisi | 88.32M | -9.57% |
Kiwango cha faida halisi | 16.95 | -11.63% |
Mapato kwa kila hisa | 0.61 | 7.83% |
EBITDA | -207.22M | -228.42% |
Asilimia ya kodi ya mapato | 29.82% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.15B | 9.00% |
Jumla ya mali | 5.69B | -6.96% |
Jumla ya dhima | 2.12B | -8.02% |
Jumla ya hisa | 3.57B | — |
hisa zilizosalia | 216.12M | — |
Uwiano wa bei na thamani | 2.58 | — |
Faida inayotokana na mali | -10.57% | — |
Faida inayotokana mtaji | -12.03% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 88.32M | -9.57% |
Pesa kutokana na shughuli | 191.51M | 26.52% |
Pesa kutokana na uwekezaji | -6.78M | 88.39% |
Pesa kutokana na ufadhili | -488.98M | -6,475.79% |
Mabadiliko halisi ya pesa taslimu | -309.43M | -451.03% |
Mtiririko huru wa pesa | -22.03M | -65.40% |
Kuhusu
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in respectively Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
29 Nov 1984
Makao Makuu
Tovuti
Wafanyakazi
5,800
